Pentavac 0.5ml Vaccine
Rx RequiredSalt Composition: Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus, Conjugate Vaccine
Expiry Date: 01/2028
Enquire
Inclusive of all taxes
1
Prescription RequiredPentavac 0.5ml Vaccine
1
Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus, Conjugate Vaccine
Salt Composition
Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus, Conjugate Vaccine
Storage
2–8°C
Expiry Date
01/2028
Marketer
Serum Institute of India Pvt Ltd
Brand
Pentavac
5966.png&w=1920&q=75 "Special offer gift")
MAGIC DEALS
Enquire
Apply Promo Code
Available CouponsPentavac 0.5ml Vaccine
Inclusive of all taxes
In Stock
Authorized
526566998m.png&w=78&q=75 "Global Reach"){kind=small}
Global Reach
Verified Logistics
The price displayed is inclusive of applicable taxes. Any additional fee (such as shipping fee, handling and/or platform fee etc.) will be clearly disclosed before you complete your purchase.
About The Product
Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus, Conjugate Vaccine
Overview
Pentavac 0.5ml is a vaccine that protects against five diseases (pentavalent), namely tetanus, diphtheria, pertussis (whooping cough), Haemophilus influenzae type b (Hib), and hepatitis B.
It contains the toxoid of tetanus, diphtheria, the surface antigen of hepatitis B, and the whole cell of pertussis bacteria, all of which are adsorbed on an adjuvant made of aluminum to trigger the immune response. Pentavac 0.5ml is given routinely to infants in three doses at 6, 10, and 14 weeks of age.
It is an adsorbed liquid formulation that is ready to use. Always consult your doctor before taking the vaccine, especially if you have a family history of blood disorders, heart problems, lung problems, pain in the limbs, or kidney problems. Also, let the medical healthcare team know if your child is allergic to any medicine.
Pentavac 0.5ml Vaccine Uses and Indications
Prevention of Tetanus
Prevention of Pertussis
Prevention of Diphtheria
Prevention of Hepatitis B infection
Prevention of Haemophilus influenzae Type b disease
Pentavac 0.5ml Vaccine Side Effects
Undesired symptoms or responses vary from individual to individual as the human body reacts differently to the Pentavac 0.5ml Vaccine , but they disappear naturally within a few days as the body adjusts to the vaccine, which requires no medical attention. In case these symptoms don't go away and you face severe side effects, then immediately consult your doctor or medical team.
Some of the common side effects of the vaccine are:
Loss of appetite
Irritation
Vaccine site reactions (pain, swelling, redness)
Skin rash
Fever
Pentavac 0.5ml Vaccine Dosage and How To Take It
The Pentavac 0.5ml Vaccine is given into the thigh muscles of infants. It is an intramuscular vaccine. Do not use the same vaccine or syringe for another vaccine, as there is a chance of interaction. This vaccine is given routinely to infants in three doses at 6, 10, and 14 weeks of age.
It is an adsorbed liquid formulation that is ready to use. Always consult your doctor before taking the vaccine, especially if you have a family history of blood disorders, heart problems, lung problems, pain in the limbs, or kidney problems. Also, let the medical healthcare team know if your child is allergic to any medicine.
How Pentavac 0.5ml Vaccine Works
Pentavac 0.5ml is a vaccine that contains the toxoid of tetanus, diphtheria, the surface antigen of hepatitis B, and the whole cell of pertussis bacteria, all of which are adsorbed on an adjuvant made of aluminum to trigger the immune response. When this vaccine is given to an individual then it stimulates the immune system to produce specific antibodies against the toxins, but doesn’t cause disease.
These antibodies and memory cells formed after taking the vaccine identify and counteract the toxins and generate memory for it, and neutralize it with a stronger immune response upon subsequent exposure within a few hours. This provides immunity within 2 to 4 weeks and for many years.
Safety Advice for Pentavac 0.5ml Vaccine
Avoid the consumption of alcohol while taking Pentavac 0.5ml Vaccine, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.
Breastfeeding women should discuss the potential risks and benefits of the Pentavac 0.5ml Vaccine with their healthcare provider before starting treatment.
Pentavac 0.5ml Vaccine may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving
The Pentavac 0.5ml Vaccine is considered safe for people with kidney problems, including individuals on dialysis. This vaccine is considered safe for people with kidney problems, including individuals on dialysis. Although the immune response may be reduced in patients having kidney problems but it is generally recommended to take the vaccine after discussing with your doctor or medical experts.
The Pentavac 0.5ml Vaccine is generally considered beneficial and safe for people with chronic liver disease, and vaccination is strongly recommended for people who are at high risk of getting severe tetanus, Diphtheria, and Pertussis
FAQs About Pentavac 0.5ml Vaccine
Pentavac 0.5ml Vaccine is given to infants in 3 doses starting from 1st dose given after 6 weeks, 2nd dose after 10 weeks and 3rd week after 14 weeks.
References
Desai, S., Rathi, N., Kawade, A., Venkatramanan, P., Kundu, R., Lalwani, S. K., ... & Kulkarni, P. S. (2018). Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine. Vaccine , 36 (37), 5519-5523.
Bagattini, A. M., Quarti, M. M., S. Martinez-Silveira, M., Policena, G., E. Coelho, L., M. Luz, P., ... & M. Toscano, C. (2022). Systematic review of immunogenicity and duration of immunity of currently licensed pertussis wP vaccines in children. Gates Open Research , 6 , 101.
Zepp, F., Knuf, M., Heininger, U., Jahn, K., Collard, A., Habermehl, P., ... & Sänger, R. (2004). Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Vaccine , 22 (17-18), 2226-2233.
Li, Y., Li, R. C., Ye, Q., Li, C., Liu, Y. P., Ma, X., ... & Mesaros, N. (2017). Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants. Human vaccines & immunotherapeutics , 13 (3), 588-598.
Klein, N. P., Abu-Elyazeed, R., Cheuvart, B., Janssens, W., & Mesaros, N. (2019). Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States. Human Vaccines & Immunotherapeutics , 15 (4), 809-821.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75 "Venika Choudhary")
.png%3FupdatedAt%3D1763121181806&w=128&q=75 "Dr. Aditya Sarin")
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.png&w=48&q=75 "Cart"){kind=small}
9655.png&w=48&q=75 "Home"){kind=small}
